These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
836 related articles for article (PubMed ID: 19189905)
1. Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection. Hundt S; Haug U; Brenner H Ann Intern Med; 2009 Feb; 150(3):162-9. PubMed ID: 19189905 [TBL] [Abstract][Full Text] [Related]
2. Quantitative immunochemical fecal occult blood testing for colorectal adenoma detection: evaluation in the target population of screening and comparison with qualitative tests. Haug U; Hundt S; Brenner H Am J Gastroenterol; 2010 Mar; 105(3):682-90. PubMed ID: 19953091 [TBL] [Abstract][Full Text] [Related]
3. A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Levi Z; Rozen P; Hazazi R; Vilkin A; Waked A; Maoz E; Birkenfeld S; Leshno M; Niv Y Ann Intern Med; 2007 Feb; 146(4):244-55. PubMed ID: 17310048 [TBL] [Abstract][Full Text] [Related]
4. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. van Rossum LG; van Rijn AF; Laheij RJ; van Oijen MG; Fockens P; van Krieken HH; Verbeek AL; Jansen JB; Dekker E Gastroenterology; 2008 Jul; 135(1):82-90. PubMed ID: 18482589 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the performance of guaiac-based and two immunochemical fecal occult blood tests for identifying advanced colorectal neoplasia in Taiwan. Ou CH; Kuo FC; Hsu WH; Lu CY; Yu FJ; Kuo CH; Wang JY; Wu MT; Shiea J; Wu DC; Hu HM J Dig Dis; 2013 Sep; 14(9):474-83. PubMed ID: 23701988 [TBL] [Abstract][Full Text] [Related]
6. Fresh vs Frozen Samples and Ambient Temperature Have Little Effect on Detection of Colorectal Cancer or Adenomas by a Fecal Immunochemical Test in a Colorectal Cancer Screening Cohort in Germany. Chen H; Werner S; Brenner H Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1547-1556.e5. PubMed ID: 27793749 [TBL] [Abstract][Full Text] [Related]
7. Contribution of the OC Sensor Vitellius C; Laly M; Banaszuk AS; Deherce I; Cornet N; Bertrais S; Saulnier P; Caroli-Bosc FX Eur J Epidemiol; 2019 Feb; 34(2):163-172. PubMed ID: 30536183 [TBL] [Abstract][Full Text] [Related]
8. Guaiac-based faecal occult blood tests versus faecal immunochemical tests for colorectal cancer screening in average-risk individuals. Grobbee EJ; Wisse PHA; Schreuders EH; van Roon A; van Dam L; Zauber AG; Lansdorp-Vogelaar I; Bramer W; Berhane S; Deeks JJ; Steyerberg EW; van Leerdam ME; Spaander MC; Kuipers EJ Cochrane Database Syst Rev; 2022 Jun; 6(6):CD009276. PubMed ID: 35665911 [TBL] [Abstract][Full Text] [Related]
9. Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer. Denters MJ; Deutekom M; Bossuyt PM; Stroobants AK; Fockens P; Dekker E Gastroenterology; 2012 Mar; 142(3):497-504. PubMed ID: 22108194 [TBL] [Abstract][Full Text] [Related]
10. Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening. Park DI; Ryu S; Kim YH; Lee SH; Lee CK; Eun CS; Han DS Am J Gastroenterol; 2010 Sep; 105(9):2017-25. PubMed ID: 20502450 [TBL] [Abstract][Full Text] [Related]
11. Comparison of a New-generation Fecal Immunochemical Test (FIT) With Guaiac Fecal Occult Blood Test (gFOBT) in Detecting Colorectal Neoplasia Among Colonoscopy-referral Patients. Guimarães DP; Fregnani JH; Reis RM; Taveira LN; Scapulatempo-Neto C; Matsushita M; Silva SRM; Oliveira CZ; Longatto-Filho A; Eklund C; Paloheimo L; Mauad E; Suovaniemi O; Syrjänen K Anticancer Res; 2019 Jan; 39(1):261-269. PubMed ID: 30591467 [TBL] [Abstract][Full Text] [Related]
15. The sensitivity and specificity of guaiac and immunochemical fecal occult blood tests for the detection of advanced colonic adenomas and cancer. Wong CK; Fedorak RN; Prosser CI; Stewart ME; van Zanten SV; Sadowski DC Int J Colorectal Dis; 2012 Dec; 27(12):1657-64. PubMed ID: 22696204 [TBL] [Abstract][Full Text] [Related]
16. A Comparison of Fecal Immunochemical and High-Sensitivity Guaiac Tests for Colorectal Cancer Screening. Shapiro JA; Bobo JK; Church TR; Rex DK; Chovnick G; Thompson TD; Zauber AG; Lieberman D; Levin TR; Joseph DA; Nadel MR Am J Gastroenterol; 2017 Nov; 112(11):1728-1735. PubMed ID: 29016558 [TBL] [Abstract][Full Text] [Related]
17. Identification of colorectal adenomas by a quantitative immunochemical faecal occult blood screening test depends on adenoma characteristics, development threshold used and number of tests performed. Rozen P; Levi Z; Hazazi R; Waked A; Vilkin A; Maoz E; Birkenfeld S; Leshno M; Niv Y Aliment Pharmacol Ther; 2009 Apr; 29(8):906-17. PubMed ID: 19183147 [TBL] [Abstract][Full Text] [Related]
18. Comparison between a guaiac and three immunochemical faecal occult blood tests in screening for colorectal cancer. Faivre J; Dancourt V; Denis B; Dorval E; Piette C; Perrin P; Bidan JM; Jard C; Jung S; Levillain R; Viguier J; Bretagne JF Eur J Cancer; 2012 Nov; 48(16):2969-76. PubMed ID: 22572481 [TBL] [Abstract][Full Text] [Related]
19. Performance characteristics and comparison of two immunochemical and two guaiac fecal occult blood screening tests for colorectal neoplasia. Rozen P; Knaani J; Samuel Z Dig Dis Sci; 1997 Oct; 42(10):2064-71. PubMed ID: 9365136 [TBL] [Abstract][Full Text] [Related]